Diabetes And Endocrinology public
[search 0]
More
Download the App!
show episodes
 
Artwork
 
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
  continue reading
 
Artwork

1
Listen to The Lancet Diabetes & Endocrinology

The Lancet Diabetes & Endocrinology

Unsubscribe
Unsubscribe
Monthly
 
The Lancet Diabetes and Endocrinology is a monthly journal that publishes high-quality peer-reviewed research, reviews, and analysis from around the world. In the podcasts, editors of the journal discuss timely news, views, research, and reviews in diabetes, endocrinology, and metabolism.
  continue reading
 
Thanks for tuning in! I'm a medical doctor and Specialist in Endocrinology and Metabolism in Canada, and I'm also certified as a Diplomate of the American Board of Obesity Medicine. Why do I blog and podcast about weight management, obesity, and diabetes? Well, there is a LOT of misinformation out there, so I'm here to provide a resource that you (as a person/patient or as a health care provider) can trust! I bring to you hot topics, new science, and breaking news, with some mythbusting mixe ...
  continue reading
 
Editors at The Lancet Diabetes & Endocrinology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from thyroid cancer to childhood obesity, the mechanisms of ageing to erectile dysfunction, and more.
  continue reading
 
As the number of Americans living with diabetes continues to rise, staying up to date on the latest diabetes research is more essential than ever to help patients achieve glucose control. With Diabetes Discourse, you’ll hear from diabetes and endocrinology experts on emerging research, diagnostic and treatment strategies, and various elements that impact a patient’s disease course, including risk factors, vitamin and mineral supplementation, physical activity, and kidney disease. Because whe ...
  continue reading
 
Revealing Retina highlights the latest treatment advances and clinical research in retinal medicine from thought leaders in the field. This series features discussions about best practices in patient retinal care and the most recent developments in combating retinal diseases. Presented by
  continue reading
 
Artwork

1
Hormones: The Inside Story

Society for Endocrinology

Unsubscribe
Unsubscribe
Monthly
 
Uncover the truth about how hormones affect stress, sleep, body fat, fertility and almost every aspect of our daily lives and health in this new, expert-led, myth-busting (often amusing) podcast. Hormones: The Inside Story is a podcast series from the Society for Endocrinology taking a look at the stories and the science behind our hormones. Find out more at www.yourhormones.info
  continue reading
 
This Endocrine Review Course is hosted by Dr. Saif Borgan, who is a board certified endocrinologist practicing in the Unites States. After completing his fellowship in Endocrinology at The Cleveland Clinic, his next goal is to advance the understanding of endocrinology among healthcare providers and trainees. This is the first free (Board-focused) Endocrinology Review podcast made for practicing-endocrinologists, fellows-in-training and advance practice providers, wishing to ACE their endocr ...
  continue reading
 
Artwork

1
AACE Clinical Conversation Series - Podcast

American Association of Clinical Endocrinologists (c) 2006

Unsubscribe
Unsubscribe
Monthly
 
Watch as Dr. Carlos Hamilton asks the tough questions in these 15 minute topical discussions. Each Conversation is a fast-paced discussion between leading experts and is focused on topics that are important to you. You'll hear leading experts explore new research and provide insights into how emerging data affects your clinical practice
  continue reading
 
Loading …
show series
 
One in three Canadian adults will get shingles at some point in their life. Shingles can be extremely painful, can occur in devastating locations, and can cause debilitating pain that can last months afterwards. Learn about the vaccine that can powerfully reduce the risk of getting shingles here! Learn more: https://drsue.ca/2024/07/should-you-get-…
  continue reading
 
Only a small fraction of people who may benefit from weight management medication are actually being prescribed treatment. What are the barriers to use of weight management medication, and how can we overcome them? Learn more: https://drsue.ca/2024/07/what-are-the-barriers-to-use-of-weight-management-medication-and-how-can-we-overcome-them/ Any med…
  continue reading
 
Once weekly basal (long acting) insulin is now available in Canada - the first country in the world to start using it. Find out more about insulin icodec (Awiqli) here! Learn more: https://drsue.ca/2024/07/once-weekly-insulin-now-available-in-canada/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended …
  continue reading
 
A study just published in JAMA Opthalmology has been a big news topic this week, suggesting an association between semaglutide (Ozempic or Rybelsus for diabetes, Wegovy for weight loss) and nonarteritic anterior ischemic optic neuropathy (NAION), which can cause blindness. What’s the scoop? Learn more: https://drsue.ca/2024/07/can-semaglutide-ozemp…
  continue reading
 
Professor Ponnusamy Saravanan, Dr Uma Ram, and Dr Kosgei Wycliffe join Lauren Southwell to discuss STRiDE, a prospective cohort study in India and Kenya, and the multi-ethnic PRiDE cohort in the UK to assess early pregnancy HbA1c as a screening test for gestational diabetes. Continue this conversation on social! Follow us today at... https://twitte…
  continue reading
 
There are currently no medications to treat sleep apnea. Could tirzepatide (Zepbound/Mounjaro) treat sleep apnea along with providing weight loss? Learn more: https://drsue.ca/2024/06/can-tirzepatide-mounjaro-zepbound-treat-obstructive-sleep-apnea/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended fo…
  continue reading
 
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/ZKT865. CME/CE/…
  continue reading
 
Some people may lose too much muscle with weight loss medication. In preventing or rebuilding lost muscle, which is more important - dietary protein or physical activity? Learn more: https://drsue.ca/2024/06/preventing-or-rebuilding-muscle-loss-from-weight-loss-medication-is-dietary-protein-or-exercise-more-important/ Any medical discussion on this…
  continue reading
 
COVID-19 in Patients with Heart Disease and Cancer Dr RR Baliga's 'Got Knowledge Doc' Podcasts for Physicians Coronaviruses and the Cardiovascular System Coronavirus Fulminant Myocarditis Case Review COVID-19 in Patients with Cardiovascular Disease and Cancer Sarju Ganatra, Sarah P. Hammond, Anju Nohria JACC: CardioOncology:Accessed online March 20…
  continue reading
 
Elevated weight can be a cause or contributor to hypertension. Why is it so important to watch your blood pressure if you are on weight management medication? Learn more: https://drsue.ca/2024/06/watching-blood-pressure-on-weight-loss-medication-why-is-this-important/ Any medical discussion on this podcast is intended to be of a general nature only…
  continue reading
 
Obesity: are environmental chemicals at the center of the storm? Find out where these chemicals may reside.... even in our nonstick cookware. Eeew. Learn more: https://drsue.ca/2024/05/obesity-are-environmental-chemicals-at-the-center-of-the-storm/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended fo…
  continue reading
 
We know that GLP1 medications reduce protein in the urine in people with type 2 diabetes and kidney disease, but no study had ever been done to see whether GLP1 treatment could protect kidney function – until now. Learn more: https://drsue.ca/2024/05/semaglutide-first-glp1-medication-proven-to-provide-kidney-protection/ Any medical discussion on th…
  continue reading
 
Nature NEWS AND VIEWS 14 May 2024 The phenomenon of genomic imprinting was discovered 40 years ago Some genes carry an ‘imprint’ on either the maternal or the paternal copy, which determines whether or not that copy is expressed. This 1984 discovery changed how scientists think about gene regulation and inheritance. By Anne C. Ferguson-Smith & Mari…
  continue reading
 
Dr RR Baliga's 'GOT KNOWLEDGE DOC' Podcasts for Physicians: Cardio-Oncology Rehabilitation in Cancer Patients and Survivors derived from Cardio-Oncology Rehabilitation in Cancer Patients and Survivors: AHA Scientific Statement Circulation. 2019;139:e997–e1012 Not Medical Advice or OpinionBy MasterMedFacts.com
  continue reading
 
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Ian de Boer, MD Since up to 40 percent of patients with diabetes develop diabetic kidney disease, it’s essential to know how to proactively diagnose and treat them using the latest therapeutic advances and strategies. Tune in to hear Dr. Mary Katherine Cheeley discuss diabetes management …
  continue reading
 
We know that GLP-1 receptor agonist medications reduce heart attack and stroke risk in people with diabetes, and in people with obesity. But what happens to risk of cardiovascular events if GLP-1 receptor agonist treatment is stopped? Learn more: https://drsue.ca/2024/05/does-heart-attack-and-stroke-risk-go-up-after-stopping-glp1-receptor-agonists/…
  continue reading
 
This episode explores the therapeutic potential of singing for cardiovascular health, highlighting its benefits on respiratory function, emotional well-being, and heart rate variability. It discusses the physiological responses to singing, comparable to moderate exercise, and emphasizes the need for further research to validate these findings. Join…
  continue reading
 
Guest: Elena Toschi, MD Approximately over the last decade, lifespans in the general population have increased, along with a rise in the prevalence of type 1 diabetes in older adult patients. Since each patient has a unique disease, the clinician should personalize and devise the best approach to diabetes management and glycemic targets, as well as…
  continue reading
 
Wegovy (semaglutide for weight management) is now available in Canada! What do you need to know? Learn more: https://drsue.ca/2024/05/semaglutide-2-4mg-wegovy-for-weight-management-now-at-canadian-pharmacies/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is n…
  continue reading
 
As the global shortage of highly effective weight management and diabetes medications (Ozempic, Wegovy, Mounjaro, Zepbound) continues, who should get priority to new starts? Learn more: https://drsue.ca/2024/04/what-is-fair-allocation-of-glp1-based-medications-during-the-global-shortages/ Any medical discussion on this podcast is intended to be of …
  continue reading
 
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2203690#.YsoGdaAS_fY.twitter DESTINY-Changing Results for Advanced Breast Cancer | NEJM https://www.nejm.org/doi/full/10.1056/NEJMe2206661#.YsoGjty1ahE.twitter Early Detection and Monitoring of Vulnerable Myocardium in Pat…
  continue reading
 
As many as 1 BILLION adults worldwide are estimated to have obstructive sleep apnea (OSA), and 70% of people with OSA have obesity. How much does sleep apnea improve with weight loss, and does it matter how the weight is lost (with lifestyle, weight management medication, or bariatric surgery)? Learn more: https://drsue.ca/2024/04/how-much-does-sle…
  continue reading
 
Semaglutide 2.4mg (Wegovy) has now been shown to effectively treat symptoms of heart failure in people with or without diabetes. What do the new data teach us? Learn more: https://drsue.ca/2024/04/weight-management-medication-semaglutide-wegovy-for-heart-failure-what-do-new-data-in-people-with-diabetes-teach-us/ Any medical discussion on this podca…
  continue reading
 
Host: John Buse, MD, PhD Guest: Kim Boggess, MD The most common forms of diabetes encountered in pregnant patients include gestational diabetes and preexisting type 2 diabetes. So how does adding metformin to insulin treatment help these patients? Join Dr. John Buse as he talks about the MOMPOD Trial with lead author, Dr. Kim Boggess, Professor of …
  continue reading
 
Older data have shown that obesity medications are prescribed far less frequently than medications for other chronic medical conditions. Much has changed in recent years in the weight management world. How has this impacted prescribing of weight management medication? Learn more: https://drsue.ca/2024/04/how-many-people-with-obesity-actually-receiv…
  continue reading
 
Guest: R. Paul Wadwa, M.D. Since young kids have a different activity level and diet than older kids or adult patients, controlling type 1 diabetes in younger patients can be more challenging, and there tends to be more variability in their blood sugars. However, a recent study identified that hybrid closed-loop technology could help give children …
  continue reading
 
Host: Carol Wysham, MD Guest: A. Michael Lincoff, MD Given the growing evidence that obesity is associated with increased cardiovascular risk, a recent study assessed the impact of semaglutide on cardiovascular outcomes in patients who are overweight or obese but do not have diabetes. Not only did semaglutide reduce the risk of cardiovascular death…
  continue reading
 
Articles have gone viral this week regarding women getting pregnant on diabetes/weight management GLP1-based medications, particularly semaglutide (Ozempic for diabetes, Wegovy for weight management) and tirzepatide (Mounjaro for diabetes, Zepbound for weight management). What do you need to know? Learn more: https://drsue.ca/2024/04/mounjaro-ozemp…
  continue reading
 
Loading …

Quick Reference Guide